ReviewApplied health economics and health policy2025
Measuring and Valuing Health Using EuroQol Instruments: New Developments 2025 and Beyond.
Review in Applied health economics and health policy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Patient-reported outcomes and experience measures in the Community Pharmacy setting: Theoretical and practical framework regarding the PROMs and PREMs.Farmaceuticos comunitarios · 2026Review
- Construct validity and responsiveness of EQ-5D-3L and EQ VAS in psoriatic arthritis: an evaluation based on the Swedish Rheumatology Quality Register.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026Article
- Comparative exploration of EQ-5D-5L bolt-on variants for fatigue, sleep, and vision in a general population sample.Health and quality of life outcomes · 2026Article
- Explaining inequalities in quality of life: a longitudinal study of health disparities in Norway.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026Article
- Comparative performance of EQ-5D-5L bolt-ons in China and the Netherlands: results from the EQ-DAPHNIE project.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026Article
- Article
- Health-related quality of life changes in patients with Q-fever fatigue syndrome: a four-year follow-up study, 10 years post-infection.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026Observational
- Protocol for the health economic evaluation of nature-based social prescribing against loneliness alongside the RECETAS trials.BMC public health · 2026Article
- A direct comparison of the measurement properties of the PROMIS-16 and EQ-5D-5L in the U.S. general population.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026Article
- Measuring health-related quality of life in infants and toddlers: conceptual challenges and proposed recommendations.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026Article
- EQ-5D-5L Values and Determinants for a Vietnamese Population.Applied health economics and health policy · 2026Article
- The value of EQ-5D-3L and EQ VAS as a patient-reported outcome measure for patients with ankylosing spondylitis in routine healthcare: an evaluation of construct validity and responsiveness based on the Swedish Rheumatology Quality Register.Journal of patient-reported outcomes · 2026Article
- Developing the EuroQol toddler and infant populations (EQ-TIPS) instrument: qualitative analysis of expert views on content validity and conceptual challenges.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The health-related quality of life (HRQoL) instruments developed by EuroQol, an international not-for-profit organisation, have earned a unique position in health economics and outcomes research. The original instrument, EQ-5D-3L, aimed to provide a concise, generic way of measuring and valuing HRQoL in adults that would enable broad comparability of HRQoL across populations and facilitate estimation of quality-adjusted life years (QALYs). These goals remain central to efforts to develop new instruments; to strengthen methods and evidence in measuring and valuing HRQoL; and to expand the use of HRQoL evidence to improve decision making. These initiatives are facilitated by the EuroQol Research Foundation's funding of research and provision of support for instrument users; the commitment of an international community of researchers; and the support of a professional staff team. This paper provides an overview of EuroQol's current suite of instruments: EQ-5D-3L and EQ-5D-5L (for adults) and EQ-5D-Y-3L and EQ-5D-Y-5L (for children) and key elements of its current research agenda. We summarise research underway to expand measurement to very young children (EQ-TIPS), and to expand what is measured (the EuroQol Health and Wellbeing instrument EQ-HWB; and the EQ-5D Bolt-on Toolbox). Research is also generating new valuation methods-such as the development of discrete choice experiment methods that incorporate duration and account for time preference-and strengthening the application of instruments, e.g., to monitor population health and health inequalities (EQ-DAPHNIE). We conclude by highlighting ongoing challenges and their implications for the future of measurement and valuation of HRQoL.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.